Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Odense University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Danish Heart Foundation
Hjernesagen
Funen County
Information provided by:
Odense University Hospital
ClinicalTrials.gov Identifier:
NCT00228098
First received: September 26, 2005
Last updated: September 27, 2005
Last verified: September 2005
  Purpose

Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.

The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.


Condition Intervention
Stroke
Transient Ischemic Attack
Behavioral: Smoking cessation

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack. A Randomised Controlled Trial

Resource links provided by NLM:


Further study details as provided by Odense University Hospital:

Primary Outcome Measures:
  • Smoking cessation rate

Estimated Enrollment: 300
Study Start Date: February 2005
Estimated Study Completion Date: February 2007
Detailed Description:

Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.

The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.

Patients with stroke or transient ischemic attack are admitted to the department of neurology at Odense University hospital. Patient who are smokers on admission and age < 76 years, inhabitants in Funen County and with symptoms developed before admission will be offered participation in the study unless they have severe stroke, stroke more than 3 weeks before admission, other severe disease or unable to participate.

Study participants will be randomised to either usual short advise on smoking cessation or an intensive smoking cessation program. All participants will be followed-up for 6 months with regard to smoking habits.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age < 76 years
  • Inhabitant in Funen County
  • Acute stroke or transient ischemic attack
  • Symptoms with onset before admission
  • Current smoker on admission

Exclusion Criteria:

  • Severe stroke
  • Current stroke onset more than 3 weeks before admission
  • Other severe disease
  • Unable to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00228098

Locations
Denmark
Department of Neurology Recruiting
Odense, Funen, Denmark, 5000 C
Contact: Søren Bak, MD, PhD.       bak@hunderupnet.dk   
Sponsors and Collaborators
Odense University Hospital
Danish Heart Foundation
Hjernesagen
Funen County
Investigators
Principal Investigator: Søren Bak, MD, PhD Department of Neurology, Odense University Hospital. 5000 Odense C. Denmark
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00228098     History of Changes
Other Study ID Numbers: VF 20040136
Study First Received: September 26, 2005
Last Updated: September 27, 2005
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Ischemic Attack, Transient
Ischemia
Stroke
Cerebral Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Pathologic Processes
Brain Infarction

ClinicalTrials.gov processed this record on July 29, 2014